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Background: Cognitive dysfunction is a primary and persisting core deficit of 
schizophrenia that is marginally improved by antipsychotic treatment. Adult mice that 
lack the stable tubule-only polypeptide (STOP) have neurochemical and behavioural 
abnormalities that model some features of schizophrenia.  
Methods: Recognition and long-term memory in the STOP null mouse were tested using 
the novel object recognition task and an olfactory discrimination task, respectively. The 
brains from STOP null mice were examined to determine whether differences in task 
performance were associated with alterations in brain morphology 
Results: STOP null mice display deficits in both recognition and long-term memory. 
STOP null mice display massive enlargement of the cerebral ventricular system, 
accompanied by reductions in volume of cortical and diencephalic structures.  
Conclusions: STOP null mice display recognition, long-term memory and 
neuroanatomical deficits reminiscent of those observed in schizophrenia. 
  









Cognitive deficits associated with schizophrenia have become increasingly recognized as 
central to both the diagnosis and treatment of this psychiatric disorder (Elvevag and 
Goldberg 2000).  These deficits include problems with attention and perception, problem 
solving, short- and long-term memory and, in particular, working memory, that often 
occur prior to the first psychotic episode and persist throughout the course of illness 
(Peuskens et al 2005). Unfortunately, these cognitive impairments are largely 
unresponsive to current antipsychotic treatments (Hagan and Jones 2005). 
Currently there is no universal animal model with which to study schizophrenia. 
Existing models are based on both the neurodevelopmental and genetic principles thought 
to underlie the disorder. Neurodevelopmental models are based on the hypothesis that an 
intrauterine or early life event results in abnormal brain organization and maturation that 
leads to the emergence of psychosis in late adolescence or early adulthood (Rehn and 
Rees 2005). These models involve the experimental manipulation of environmental 
factors in the pre- or perinatal period of animals and generally result in a schizophrenic 
phenotype that develops at adulthood (Boksa 2004; Lipska et al 1993; Ozawa et al 2006; 
Zuckerman et al 2003).  
The genetics of schizophrenia are quite complex, and research indicates a 
relationship between various genetic polymorphisms and their interactions with the 
chemical environment during development.  There are several chromosomal regions 
encoding putative schizophrenia susceptibility genes (SSGs) that have been identified 
from genetic linkage studies within specific pedigrees, including Disrupted-in-
schizophrenia-1 (DISC-1), neuregulin-1 (Nrg-1), dysbindin, catechol-o-methyl 
transferase (COMT) and metabotropic-glutamate-receptor-3 (mGluR3) (Harrison and 
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Weinberger 2005). These genes encode proteins involved in neurodevelopment, synaptic 
plasticity and signal transduction that may contribute to the synaptic dysfunction 
observed in schizophrenia (Harrison and Weinberger 2005). Recently, animal models 
have been developed in which the functionality of SSGs or other genes involved in these 
same neural processes have been manipulated. For instance, mice in which one allele of 
the neuregulin-1 gene (regulating neural development: proliferation, migration, survival 
and differentiation) has been mutated display mild behavioral abnormalities such as 
hyperlocomotion and deficits in pre-pulse inhibition (PPI) and latent inhibition that 
recapitulate some clinical features of schizophrenia (Di Segni et al 2005; Gerlai et al 
2000; Liu et al 2005; Rimer et al 2005). As well, mice lacking calcineurin expression in 
the forebrain exhibit deficits in synaptic plasticity and neurite outgrowth, and display 
impaired episodic learning and memory (delayed matching-to-sample task), 
hyperlocomotor activity, reduced social interaction and impaired PPI and latent inhibition 
reminiscent of the psychotic, negative, and cognitive impairments observed in human 
patients (Gerber et al 2003; Miyakawa et al 2003; Zeng et al 2001). 
Mice lacking the microtubule associated protein stable tubule-only polypeptide 
(STOP) display synaptic deficits, hyper-dopaminergic activity (increased locomotor 
activity in response to a novel environment or administration of d-amphetamine) and 
behavioural abnormalities (disrupted pre-pulse inhibition, (PPI) and social withdrawal) 
that are reminiscent of symptoms observed in schizophrenia (Andrieux et al 2006; 
Andrieux et al 2002; Brun et al 2005; Fradley et al 2005).  STOP null mice also show 
long-term potentiation (LTP) and long-term depression (LTD) deficits in the 
hippocampus (Andrieux et al 2002) that may contribute to cognitive impairments in these 
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animals. Moreover, behavioural abnormalities displayed by these mice such as 
hyperactivity of the mesolimbic dopamine system and impaired maternal nurturing 
behaviour are ameliorated by antipsychotic administration (Andrieux et al 2002; Fradley 
et al 2005). In contrast, PPI or LTP deficits are not reversed by antipsychotic treatments 
(Andrieux et al 2002; Fradley et al 2005), a profile that closely resembles the clinical 
outcome achieved by these drugs in schizophrenic patients (Hagan and Jones 2005).   
 In the present study, STOP null mice were first tested for the presence of a 
hyperlocomotive phenotype, as compared to wild-type and heterozygous littermates, to 
establish consistency with previous studies. The main goal of our study was to determine 
whether STOP null mice have cognitive deficits in object recognition memory and long-
term memory as assessed by the novel object recognition task (NORT) and an olfactory 
discrimination test, respectively.  Furthermore, we also tested the STOP null mice in a 
buried food test as a control measure for motivation towards food rewards and olfactory 
skills. A histological examination of the brains from STOP null mice was performed to 
determine whether differences in task performance between STOP null and wild-type 
littermates were associated with alterations in brain morphology. Specific regions 
examined included those previously associated with schizophrenia and cognitive deficits 
including the cerebral cortex, hippocampus, basal ganglia, lateral ventricle, and thalamus, 









All mice used in this study were generated in-house from heterozygous STOP mice 
breeding pairs (C57Bl/6 and 129S1/Smvlj background (50:50)).  Litters yielded the 
expected Mendelian ratios of 25% wild-type, 50% heterozygous and 25% STOP null 
mice.  Adult mice were group-housed in ventilated cages on a 12hr light/dark cycle with 
free access to food and water except during the olfactory discrimination task and the 
buried food task during which the animals were restricted to 2-4 grams of food per day to 
maintain 85% body weight. All experiments were conducted according to the guidelines 
set forth by the Canadian Council of Animal Care and the Dalhousie University Animal 
Care Committee.   
 
Locomotor Behaviour 
Individual animals were placed in plexiglass boxes [45cm(l) x 24cm(w) x 20cm(h); size 
of standard rat cage] and allowed to roam freely. The distance moved and total time spent 
moving over a 30 min period was recorded using Ethovision Software (Noldus 
Information Technology). 
 
Novel Object Recognition Task (NORT) 
The NORT was conducted in an opaque plexiglass arena [35cm(w) x 45.5cm(l) x 
36cm(h)] using objects that could not be displaced by the animal (full, unopened Pepsi 
cans and inverted ceramic vases).  Adult male and female mice were habituated to the 
arena in the absence of objects, for 5 min on each of 2 successive days prior to the test 
day.  On the test day, the animals were habituated to the arena for one minute and then 
removed and placed in a holding cage while two identical objects were placed along the 
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length of the arena in two adjacent corners (7.5cm from each wall).  During the Sample 
Phase, each mouse was placed in the centre of the arena and the time spent exploring 
each object was recorded over a 5min period using stopwatches.  
Following a delay of 5min, during which time the animal was again placed in a 
holding cage, the animal was returned to the arena for the Choice Phase, with one object 
from the Sample Phase (familiar object) and a novel object.  Individuals unaware of the 
treatment conditions or mouse genotype recorded the time spent exploring each object 
over a 3 min period using stopwatches.  Exploration was defined as directing the nose 
towards the object at a distance less than 1cm, and included placing one or more paws on 
the object.  Sitting close to or on top of the object was not considered exploration.  
Between the Sample and Choice Phases, and between subjects, the arena and objects 
were cleaned with a 10% ethanol solution to remove odour cues.   
The total time spent investigating both objects in the Sample Phase was recorded 
and compared between the 3 different mouse genotypes.  In the Choice Phase the 
proportion of time spent with the novel object was determined by subtracting the time 
spent with the familiar object from that spent with the novel object, and dividing this time 
by the total time spent exploring both objects. The resultant value was a Discrimination 
Ratio, whereby a value of 0 indicated equal time was spent investigating both objects and 
a value of 1 indicated that all time was spent investigating the novel object.  
 
Olfactory Digging Task 
The olfactory discrimination task consisted of a four-day training session in which the 
mice were exposed sequentially to one odour paired with sugar (rewarded conditioned 
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stimulus; CS+) and a second odour presented in the absence of sugar (unrewarded 
conditioned stimulus; CS-). During the training phase, mice from the 3 groups were 
randomly divided such that half received rose odour as CS+ and lemon odour as the CS- 
while the other half received the opposite reinforcement contingence: lemon (CS+)/rose 
odour (CS-).  Each odour was presented on filter paper (Whatman no. 1, 55 mm 
diameter) that was placed on the bottom of a plastic beverage cup, cut to a 1.5 cm height 
and covered with a plastic Petri dish cover containing 10 pre-drilled holes (odour pot).  
Mice were exposed to the odour stimuli in 30 cm x 13 cm x 11.5 cm polycarbonate 
opaque cages, similar to their home cages, with the odour pots buried in Prochip® 
bedding (PWI Industries, St. Hyacinthe, Que., Canada). 
All animals received four 5-min training trials per day (two rose trials and two 
lemon trials, presented in a quasi-random order), with a 10-min interval between each 
trial. If an odour was paired with sugar reinforcement, the sugar (0.05 g) was buried in 
the bedding covering the odour pots. During each 10-min inter-trial interval, the bedding 
and filter paper in the test cages were changed and fresh odours applied to the filter 
paper.   
To determine whether the mice had learned the association between an odour and 
sugar reward, odour discrimination tests were performed 24hrs and 7 days following the 
last training day in a 69cm x 20cm x 20cm box with two pieces of acrylic dividing the 
apparatus into 3 equal chambers. Prochip® bedding was distributed over the floor of the 
box. Prior to testing, the animals were habituated for 2 min to the apparatus and then 
returned to their home cages. For the testing phase, a rose odour pot was placed at one 
end of the apparatus in one chamber and a lemon odour pot at the other end in a separate 
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chamber. The odour pots contained Prochip® bedding but no sugar. The time the mouse 
spent digging in each odour pot was recorded over a 3-min period. Digging was defined 
as moving of the bedding with either the forepaws or nose. The apparatus was cleaned 
and new odour pots and Prochip® bedding used for each mouse. Data are expressed as 
net digging time in the CS+ versus the CS-odour pot. 
 
Buried Food Test  
The buried food test was carried out according to previously described procedures with 
only minor modifications (Dawson et al 2005; Harding and Wright 1979). Testing was 
conducted over 3 days with habituation on day 1 followed by an experimental session on 
days 2 and 3. On day 1, the mice were given a single trial in which a piece of Frootloop 
was placed on top of the Prochip® bedding in the centre of the cage. Each mouse was 
placed individually into the cage and allowed to explore for 5 min. On return to the home 
cage, the mice were moderately food deprived overnight. On day 2, the experimental 
session consisted of four trials separated by a 10 min inter-trial period in the home cage. 
At the beginning of each trial, a piece of Frootloop was buried beneath 1 cm of 
Prochip® bedding in a randomly selected location. The mouse was placed in the cage and 
the time taken to find the buried Frootloop was recorded.  The mouse was then returned 
to the home cage for the 10 min inter-trial period. If the Frootloop was not found within 
5 min, then 300s was recorded for that trial. Each mouse received four trials; bedding was 
changed and a new Frootloop used for each trial. On day 3, another four trial 
experimental session was completed in an identical manner to the session on day 2. 
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Measurements of brain volume and volumes of cerebral cortex, corpus striatum, 
thalamus, hippocampus and lateral ventricles 
Animals received an overdose of sodium pentobarbital and were perfused intracardially 
with saline followed by 4% paraformaldehyde.  Brains were removed, post-fixed in 4% 
paraformaldehyde and cryoprotected in sucrose prior to sectioning (30µm) on a freezing 
microtome. The brain was sectioned in the coronal plane in an anterior-to-posterior 
direction, extending from 1.1mm anterior to bregma to 3.28mm posterior to bregma (see 
Paxinos and Franklin, 2004). Brain sections were mounted on Superfrost slides, stained 
for Nissl substance with cresyl violet, dehydrated and coverslipped.  Images of whole 
brain sections were visualized using a Zeiss (Axioscope) microscope fitted with a 1x 
objective lens.  Images were captured with an Axiocam HRc digital camera using 
imaging software (AxioVision, Zeiss). ScionImage software (Scion Corporation) was 
used to measure areas in individual sections of the entire brain, thalamus, lateral 
ventricles, corpus striatum (including the nucleus accumbens shell and core in the 
measurements), cerebral cortex, and hippocampus (results for bilateral structures were 
summed over the right and left sides from each animal).  Area measurements were 
computed in square millimeters. Principles of unbiased stereology, according to the 
Cavalieri method, were used to determine volumes of the measured structures (Mouton 
2002).  The formula used for the area-to-volume conversions was: Vref = (ΣA
1→i)T, 
where Vref refers to the calculated volume, A is the area on the face of each section 1 to 
i, ΣA
1→i is the sum of reference areas in sections 1 to i, and T is the distance between 
each section. We measured every twelfth section (the first measured section being 
determined randomly), and sections were cut at 30µm thickness, hence T = 360 µm 
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(0.36mm) in our calculations.  For each of the 3 genotypes studied (wild-type, 
heterozygous and homozygous STOP null mice), 6-9 animals were examined per group; 





All data are expressed as the mean ± S.E.M.  A one-way analysis of variance (ANOVA) 
followed by Newman-Keuls post-hoc tests, where required, was used to assess statistical 
differences between genotypes in locomotor behaviour, the NORT, and time spent 
digging in the olfactory discrimination test. A chi-square test was used to compare the 
number of diggers and non-diggers in the olfactory discrimination task. In the buried food 
task, statistical differences were determined using a repeated measures two-way ANOVA 
followed by Bonferroni post-hoc testing, with genotype and trial number as independent 
variables. A one-way ANOVA followed by Newman-Keuls post-hoc testing was used to 
detect differences in the volumes of whole brain, thalamus, ventricle, striatum, cortex and 
hippocampus. All statistical tests were performed using GraphPad Prism version 4.00 for 






In previous studies, it was shown that STOP null mice display a hyperlocomotive 
phenotype, suggestive of hyperactivity of the mesolimbic dopamine system. Comparison 
of the total distance moved over a 30 min period, revealed that STOP mull mice moved a 
significantly longer distance than did wild-type and heterozygous mice (Figure 1A; 
ANOVA, F=4.117, p=0.03). In addition, the STOP null mice spent significantly more 
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time moving over the 30 min period (Figure 1B; ANOVA, F=4.425, p=0.02), indicating a 
basal level of locomotor activity that is greater in the STOP null versus wild-type and 
heterozygous mice.   
 
The NORT exploits a rodent’s innate preference for novelty and is a measure of 
object recognition memory. During the Sample Phase of the NORT (Figure 2A), no 
significant differences were found in the amount of time that the wild-type, heterozygous 
and STOP null mice spent exploring the two identical objects (ANOVA, F=1.588, 
p=0.22), suggesting that all mice were motivated to perform this task.  During the choice 
phase(Figure 2B); however, when a familiar object from the sample phase was replaced 
with a novel object, a comparison of Discrimination Ratios revealed that STOP null mice 
spent significantly less time exploring the novel object compared to wild-type and 
heterozygous STOP mice (ANOVA, F=5.045, p=0.01).  Thus, STOP null mice were less 
able to recognize or distinguish a familiar object following a delay of 5 min, suggesting a 
profound deficit in novel object recognition memory. There was no significant difference 
between the performance of the wild-type and heterozygous STOP mice.  
 Long-term memory was assessed using an olfactory discrimination task that 
required the animals to learn and remember an odour-reward based association.  During 
the training phase, all animals approached both the CS+ and CS- odour pots and were 
observed digging for, and eating the buried sugar upon presentation in the CS+ odour pot. 
Twenty-four hours following the four-day training period, all three groups of mice 
showed a distinct preference for the odour that was previously associated with a reward 
as demonstrated by digging behaviour predominantly in the CS+ odour pot that lasted for 
approximately 21s (Figure 3A). In the rare instance that a mouse was observed digging in 
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the CS- odour pot, it was for a period of only 1-2 seconds, and all graphed data reflects 
the net time digging in the CS+ odour pot. Although the STOP null mice spent an 
average amount of time digging that was not significantly different from wild-type or 
heterozygous STOP mice (ANOVA, F=0.1064, p=0.90), several STOP null animals did 
not display digging behaviour in the previously rewarded odour pot (Figure 3A). In fact, 
6 of the 17 STOP null mice tested did not dig at all, compared to only 2 heterozygous 
mice and one wild-type mouse. A chi-square analysis revealed a significant difference in 
the number of diggers versus non-diggers in the groups of wild-type, heterozygous and 
STOP null mice (Figure 2B, chi-square=6.039, df=2, p=0.048). These results suggest that 
a significant number of the STOP null mice were unable to either learn the odour-reward 
based association or remember this association 24 hrs post-training. 
 Memory for the odour-reward based association was also tested at 7 days 
following training. As shown in Figure 3C, the wild-type and heterozygous STOP mice 
still showed a preference for the previously rewarded odour indicated by elevated time 
spent digging in the odour pot associated with reward.  In contrast, STOP null mice spent 
less time digging in the previously rewarded odour pot compared to wild-type and 
heterozygous mice (ANOVA, F=3.311, p=0.046).  Interestingly, most of the STOP null 
mice did not dig for the reward at all, compared to approximately one-half of the 
heterozygous mice and only 2 of the wild-type mice. A chi-square analysis revealed a 
significant difference in the number of diggers versus non-diggers in the wild-type, 
heterozygous and STOP null mice at this 7 day time point (Figure 3D; chi-square=13.45, 
df=2, p=0.001). These results indicate that STOP null mice (are unable) (have greater 
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difficulty) to remember an odour-reward based association following a 7 day delay after 
training, suggesting that these mice may have deficits in long-term memory. 
 The olfactory discrimination task relies on the fact that food-deprived animals are 
motivated to dig for food reward, in this case sugar, and will associate the reward with an 
odour.  The deficits displayed by the STOP null mice in the olfactory digging task would 
be confounded if the animals were not motivated to search for a food reward or suffered 
from olfactory deficits.  To assess olfaction in the STOP null mice we examined their 
performance in a buried food test. Following food deprivation, the wild-type and STOP 
null mice actively searched for, found and ate the buried Frootloop®.  On average, mice 
were able to find the buried Frootloop® in under the 300 second cut-off on the first day 
of testing and the time to perform this task further decreased over successive trials on the 
second day (Figure 4). Consequently, wild-type and STOP null mice performed at 
comparable levels in this test, with no significant effect of genotype or trial session on 
either day. These data suggest that STOP null mice can smell and are motivated to find a 
food reward, implying that memory deficits rather than olfactory or motivational 
impairments were responsible for deficits in the olfactory digging test.  
Following completion of the behavioural tasks, all mice were sacrificed and brain 
sections analyzed for the presence of morphological differences between groups. 
Representative photomicrographs of brain sections taken from several brain levels are 
shown in Figures 5 and 6.  These figures clearly demonstrate that STOP null mice display 
a profound enlargement of the lateral ventricles accompanied by smaller volumes of 
cerebral cortical and subcortical regions compared to wild-type mice. Heterozygous 
STOP mice exhibited similar, but less obvious abnormalities that were determined to be 
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significant in quantitative experiments (see Figure 7).  Quantitative measurements 
indicated that STOP null mice display significantly larger cerebral ventricular volumes 
compared to wild-type (p<0.05), but not heterozygous, mice (ANOVA, F=5.108, 
p=0.0175; Figure 7A). Although there was an overall trend towards a smaller total brain 
size in STOP null mice compared to heterozygous and wild-type mice, there was no 
significant difference in total brain volume between the three different genotypes 
(ANOVA, F=1.852, p=0.1829; Figure 7B). However, the STOP null mice had 
significantly smaller striatal volumes (ANOVA, F=6.123, p<0.0084) in comparison with 
wild-type mice (p<0.01), but not heterozygotes (Figure 7C). Measurements of the 
thalamic nuclei (ANOVA, F=18.72, p<0.001) revealed that STOP null mice had 
significantly smaller volumes compared to wild-type (p<0.001) and STOP (+/-) mice 
(p<0.001) (Figure 7D).  STOP null mice also displayed significantly smaller cerebral 
cortical volumes (ANOVA, F=5.417, p=0.0138) in comparison with wild-type (p<0.05) 
and heterozygous STOP mice (p<0.05; Figure 7E). In contrast, measurements of 
hippocampal volumes revealed no significant differences between wild-type, 
heterozygous and STOP null mice (ANOVA, F0.5596, p=0.5596; Figure 7F).  
Discussion 
 
The major finding of the present manuscript is that STOP null mice display 
cognitive deficits in recognition memory. We also found that lack of the STOP protein 
leads to developmental abnormalities in brain structure resulting in an enlarged 
ventricular system accompanied by smaller than normal cerebral cortical, striatal and 
thalamic volumes. These changes may contribute to the performance deficits in tasks 
requiring object recognition or long-term memory.  
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Cognitive deficits in schizophrenia are thought to result from synaptic loss or 
aberrant connectivity (Glantz et al 2006; Lewis and Lieberman 2000). Microtubule 
associated proteins, such as STOP, play an integral role in the formation and maintenance 
of synaptic connections, vesicle trafficking and cell migration (Bosc et al 2003).  The 
importance of these types of microtubule associated proteins is demonstrated by the fact 
that deletion of doublecortin leads to massive alterations in cortical development and 
results in a lissencephaly characterized by mental retardation (Francis et al 1999).  
Deletion of the STOP protein appears to result in a more subtle phenotype, as it is 
difficult to distinguish STOP null mice from wild-type and heterozygous littermates upon 
initial observation.  Nevertheless, it has been demonstrated that the STOP protein plays 
an important role in microtubule stability and is responsible for stability under conditions 
of cold- and drug- (nocodazole) induced stress in vitro (Bosc et al 1996). Furthermore, 
inhibition of STOP activity in vitro leads to neuronal microtubule disassembly and 
hindered neurite formation, suggesting STOP plays an important role in the normal 
structure and function of neurons (Guillaud et al 1998). STOP isoforms, all of which 
contain exon 1 of the stop gene, are present in astrocytes and oligodendrocytes as well as 
neurons (Bosc et al 2003).  The STOP null mouse was generated by targeted deletion of 
exon 1, and thus a lack of STOP in any of these 3 cell types may result in the observed 
phenotype and cognitive dysfunction in these mice (Andrieux et al 2002).  
 CT and MRI studies have consistently reported ventricular enlargement in human 
schizophrenia patients (Shenton et al 2001). Our finding that STOP null mice show a 
massive enlargement of the cerebral ventricular system is particularly important in terms 
of further establishing these mice as a suitable model for schizophrenia. Although MRI 
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studies of human brain regions have often yielded conflicting results, several studies have 
shown that patients with schizophrenia display regional decreases in gray matter in the 
caudate nucleus, putamen and thalamus (Antonova et al 2004; Shenton et al 2001). Given 
the role of the basal ganglia in dopamine signaling, the importance of these structures as a 
target for neuroleptic action, and the integral function played by the basal ganglia play in 
sensory, cognitive and motor processing, it is not surprising that many studies have 
identified structural anomalies in these brain regions in schizophrenic patients (Shenton 
et al 2001).  Interestingly, the size of the basal ganglia has been correlated with the 
performance of schizophrenia patients on the Wisconsin Card Sorting Test, with poor 
performers displaying decreased basal ganglia size relative to controls and good WCST 
performers diagnosed with schizophrenia (Stratta et al 1997).  Similarly, the thalamus is a 
major relay station in the brain modulating inputs from cortical and limbic structures, and 
is involved in attention, information processing and sensory gating: processes that may be 
impaired in schizophrenia (Shenton et al 2001). Although ventricular enlargement is not a 
finding that is specific to schizophrenia, the fact that STOP null mice display this feature 
in addition to cortical, striatal and thalamic atrophy as well as cognitive deficits, hyper 
mesolimbic dopaminergic activity, social withdrawal, disrupted PPI and responsiveness 
to chronic neuroleptic administration, suggest that these mice may provide a useful 
experimental paradigm to study some elements of the etiology and treatment of 
schizophrenia (Andrieux et al 2002; Brun et al 2005; Fradley et al 2005). While there are 
many other genetic models of schizophrenia that have been developed in recent years [for 
review see (O'Tuathaigh C et al 2006)], none has been investigated as thoroughly as the 
STOP null mouse or has demonstrated as broad an array of neurochemical, 
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neuropathological, cognitive and behavioural abnormalities that closely resemble those 
observed in schizophrenia.   
Despite the fact that the STOP null mouse has only recently been characterized as 
a model of schizophrenia, these mice clearly recapitulate many of the cardinal features of 
this psychiatric disorder.  STOP null mice show deficits in behavioural correlates for all 
of  the major classes of symptoms characteristic of schizophrenia: positive, negative and 
cognitive.  In the present study we have provided more evidence for this, including 
deficits in delayed object recognition and in the long-term memory of an odour-reward 
association.  Moreover, we have also demonstrated anatomical abnormalities in the STOP 
null mouse brain, such as ventricular enlargement and abnormally small cortical and 
subcortical nuclear structures in the diencephalon.  These abnormalities are consistent 
with those that have been observed in some schizophrenic patients. Taken together, these 
findings suggest that the STOP null mouse may be a useful animal model of 
schizophrenia for future studies  
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Figure 1. Locomotor behaviour of wild-type, heterozygous and STOP null mice in an 
open field, measured as both distance moved (A) and time spent moving (B).  
*Significantly different from wild-type and heterozygous in both distance moved 
(p=0.03) and time spent moving (p=0.02). Data are presented as mean ± S.E.M. n= 7-9 
/genotype 
 
Figure 2. Performance of wild-type, heterozygous and STOP null mice in the sample 
phase (A) and choice phase (B) of the novel object recognition task. *Significantly 
different from wild-type (p<0.01) and heterozygous mice (p<0.05). Data are presented as 
mean ± S.E.M. n=12-15/genotype. 
 
Figure 3. Performance of wild-type, heterozygous and STOP null mice in the olfactory 
digging task 24 hrs (A,B) and 7 days (C,D) post-training. Average time spent digging by 
wild-type, heterozygous and STOP null mice in the previously rewarded odour pot at 
24hrs (A) and 7 days (C) post training (*p<0.05, n=15-19/genotype). Profile of the 
number of wild-type, heterozygous and STOP null mice that spent time digging or spent 
no time digging in the rewarded odour pot at 24hrs (B) and 7 days (D) post training. 
 
Figure 4. Performance of wild-type and STOP null mice in the buried food test over four 




Figure 5. Photomicrographs of cresyl violet stained coronal brain sections from wild-
type (WT; A,B,C) and STOP null mice (STOP null; D,E,F) at brain levels extending from 
1.10 to -0.70 mm from bregma.  Enlargement of the ventricles as well as abnormally 
small striatal regions are evident in sections from STOP null mice.    
 
Figure 6. Photomicrographs of cresyl violet stained coronal brain sections from wild-
type (WT; A,B,C) and STOP null mice (STOP null; D,E,F) at brain levels extending from 
-1.06 to -2.92 mm from bregma.  Enlargement of the ventricles as well as abnormally 
small thalamic nuclei are evident in sections from STOP null mice.  By contrast, ventral 
hippocampal morphology was similar in STOP null and WT littermates. Although dorsal 
hippocampal morphology appeared different in STOP null and WT littermates, there 
were no volumetric statistical differences in this structure.      
 
Figure 7. Volume (mm
3
) comparisons of the lateral ventricles (A), entire brain (B), 
corpus striatum (C), thalamus (D), cerebral cortex (E) and hippocampus (F) in wild-type, 
heterozygous and STOP null mice. Volumes of the lateral ventricles and corpora striata 
are significantly smaller in STOP null mice compared to wild-type animals (*).  Volumes 
of thalamic nuclei and cerebral cortex are significantly smaller than those of both wild-
type and heterozygous mice (*). Data are presented as mean ± S.E.M. 
 
